Cytokinetics (CYTK) PT Raised to $23 at JMP Securities
Tweet Send to a Friend
JMP Securities analyst Jason Butler raised the price target on Cytokinetics (NASDAQ: CYTK) to $23.00 (from $15.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
